<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230314057717N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-15</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Review of the least complicated technique of bile duct cannulation in difficult ERCP cases</public_title>
      <acronym>ERCP</acronym>
      <scientific_title>Comparison of two technical methods of fistulotomy over a pancreatic guide-wire and trans-pancreatic sphincterotomy in difficult cases of ERCP with advertent or inadvertent PD cannulation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>200</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69385</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are assigned to two groups using the random block method.
The number of blocks will be 4 and each block will have three patients based on the order of entry
are studied. Random allocation of blocks of patients to two treatment groups
It will be done through Sealed Envelope online software. Randomized list
The blocks are placed in sealed envelopes and will be provided to the endoscopist daily, Blinding description: The patients who are in each group do not know about which biliary duct cannulation method they have been placed in. Also, in order to avoid the bias of the analyst, he is not aware of the allocation of the study groups and the data is provided to him in the form of code.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Obstruction of the bile ducts.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the first group, the bile duct of the patients will be cannulated with the fistulotomy over the pancreatic guidewire technique. Patients will undergo ERCP in one session and its duration will be between 20 and 60 minutes depending on the difficulty of cannulation. First, a stent will be inserted in the duct of the patient's pancreas. The guidewire will then pass over the stent, and through the pancreas, into the bile duct. Intervention 2: Intervention group: In the second group, the bile duct of the patients will be cannulated with the trans pancreatic fistulotomy technique. Patients will undergo ERCP in one session and its duration will be between 20 and 60 minutes depending on the difficulty of cannulation. In this method, the endoscopist enters the pancreas with a guide wire and enters the bile duct by creating a hole in the pancreas.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The statistical analysis plan, study design and information on main outcomes will be shared

When:
After publishing the article

To whom:
Researchers, medical students, professors, and doctors

Conditions:
If used for further research and in compliance with the principle of referencing

Where to obtain:
corresponding author
َAmir Sadeghi
amirsadeghimd@yahoo.com

How to obtain:
Send the request to the responsible author and outline the reason for the request

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ehsan Hosein zadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Arabi street, Velenjak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3816149369</zip>
        <telephone>+98 21 2243 2540</telephone>
        <email>hosseinzadehehsan@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amir Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Arabi street, Velenjak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3816149369</zip>
        <telephone>+98 21 2243 2540</telephone>
        <email>amirsadeghimd@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with acute pancreatitis (increased amylase and lipase 3 times more than normal)
Patients with gallstones on ultrasound suspected to have CBD stones (symptomatic gallstone disease)
Biochemical findings (increased AST, ALP, ALT or bilirubin)
Ultrasound findings (diagnosis of stones or enlargement of the CBD) that indicate a CBD stone or blockage of the CBD</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with severe coagulopathy or previous Roux-en-y gastric surgery
Gastrogenostomy
pregnancy
Contrast sensitivity
History of previous sphincterotomy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K83.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Obstruction of bile duct</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the first group, the bile duct of the patients will be cannulated with the fistulotomy over the pancreatic guidewire technique. Patients will undergo ERCP in one session and its duration will be between 20 and 60 minutes depending on the difficulty of cannulation. First, a stent will be inserted in the duct of the patient's pancreas. The guidewire will then pass over the stent, and through the pancreas, into the bile duct.</i_keyword>
      <i_keyword>Intervention group: In the second group, the bile duct of the patients will be cannulated with the trans pancreatic fistulotomy technique. Patients will undergo ERCP in one session and its duration will be between 20 and 60 minutes depending on the difficulty of cannulation. In this method, the endoscopist enters the pancreas with a guide wire and enters the bile duct by creating a hole in the pancreas.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Success rate of bile duct cannulation. Timepoint: At the time of cannulation by the endoscopist. Method of measurement: Visual diagnosis of the endoscopist by observing the cannulation process on the monitor.</prim_outcome>
      <prim_outcome>Bleeding. Timepoint: during or after the procedure. Method of measurement: Clinical evidence of bleeding or hemoglobin drop.</prim_outcome>
      <prim_outcome>Pancreatic. Timepoint: 6 hours after the procedure. Method of measurement: Amylase and/or lipase 3 times higher than normal 24 hours after the procedure with abdominal pain.</prim_outcome>
      <prim_outcome>Perforation of bile duct. Timepoint: during the procedure. Method of measurement: Clinical evidence of perforation of the lateral or medial wall of the bile duct.</prim_outcome>
      <prim_outcome>Cholangitis. Timepoint: 6 hours after the procedure. Method of measurement: When the bile duct becomes infected (abdominal pain and fever over 38 degrees).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Temperature. Timepoint: 4 hours after the completion of the procedure. Method of measurement: thermometer.</sec_outcome>
      <sec_outcome>Amylas. Timepoint: before the procedure and 3 hours after the procedure. Method of measurement: blood test (CBC).</sec_outcome>
      <sec_outcome>Lipas. Timepoint: before the procedure and 3 hours after the procedure. Method of measurement: blood test (CBC).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-03-11</approval_date>
        <contact_name>Ethics Committee of Gastroenterology and Liver Research Institute of Shahid Beheshti University of M</contact_name>
        <contact_address>arabi street, Velenjak Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
